Broadview Ventures — 2016 Investments
1 investments dated 2016 · listed companies and verified rows first · show all
Aeromics, LLCaeromics.comApr 2016
Aeromics is a clinical-stage biopharmaceutical company developing AER-271, an aquaporin-4 inhibitor to prevent cerebral edema (brain swelling) in severe acute ischemic stroke patients.
BiotechMedical DevicesNew Haven, US
Dr. Pelletier(Founder)Dr. Boron(Founder)Frederick Jones(Director)Paul McGuirk(Executive Officer)Walter Boron(Executive Officer, Director)George Farr(Executive Officer)
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.